A pH/GSH dual-responsive ZnO2@Cu-PDA nanoplatform for synergistic therapy of breast cancer.
ROS-driven catalytic therapy holds great promise for cancer treatment, yet its therapeutic performance is severely hampered by insufficient endogenous H2O2. A core-shell ZnO2@Cu-PDA nanoplatform, composed of an acid-labile zinc peroxide core and a copper-enriched amorphous polydopamine shell, was investigated to enable...